15.13
Biodesix Inc Aktie (BDSX) Neueste Nachrichten
Biodesix Faces Mounting Reimbursement and Enforcement Risks as Evolving Payer Policies Threaten Revenue Stability - TipRanks
Biodesix Earnings Call Signals Strong Growth Momentum - TipRanks
Canaccord Genuity Group Issues Positive Forecast for Biodesix (NASDAQ:BDSX) Stock Price - MarketBeat
Biodesix touts ‘clear path toward profitability’ - BizWest
William Blair Maintains Biodesix(BDSX.US) With Buy Rating - Moomoo
Biodesix Inc. 10-Q Q1 2026: Financial Statements, Risk Factors, and Management Analysis - Minichart
Biodesix stock price target raised to $22 by Canaccord on revenue growth - Investing.com
Biodesix, Inc. (NASDAQ:BDSX) Q1 2026 Earnings Call Transcript - Insider Monkey
Biodesix, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Biodesix Q1 Earnings Call Highlights - MarketBeat
Biodesix (BDSX) Q1 2026 Earnings Transcript - The Globe and Mail
BDSX: Q1 revenue up 42% year-over-year, with raised 2026 guidance and margin expansion - TradingView
Earnings call transcript: Biodesix Q1 2026 shows revenue growth, stock steady - Investing.com
Biodesix, Inc. (BDSX) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Biodesix Inc (NASDAQ:BDSX) Q1 Results Smash Estimates, Shares Jump on Raised Guidance - ChartMill
Biodesix (NASDAQ:BDSX) Announces Earnings Results - MarketBeat
Q1 2026 Biodesix Inc Earnings Call Transcript - GuruFocus
Biodesix Announces First Quarter 2026 Results and Highlights - The Manila Times
Biodesix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Biodesix (NASDAQ: BDSX) grows Q1 2026 revenue and trims loss - Stock Titan
Biodesix lifts 2026 forecast after Q1 revenue hits $25.6M - Stock Titan
Strong Q1 for Biodesix (Nasdaq: BDSX) with 42% revenue growth - Stock Titan
MSN Money - MSN
Biodesix Inc expected to post a loss of $1.10 a shareEarnings Preview - TradingView
Earnings To Watch: Biodesix Inc (BDSX) Reports Q1 2026 Result - GuruFocus
Earnings Preview: Biodesix to Report Financial Results Post-market on May 04 - Moomoo
Biodesix (NASDAQ: BDSX) holder AIGH reports 7.7% ownership - Stock Titan
Wall Street analysts think Biodesix (BDSX) could surge 111.62%: Read this before placing a bet - MSN
BDSX Stock Price, Quote & Chart | BIODESIX INC (NASDAQ:BDSX) - ChartMill
Wall Street analysts see an 86.45% upside in Biodesix (BDSX): Can the stock really move this high? - MSN
Biodesix (BDSX) to Release Earnings on Monday - MarketBeat
Biodesix, Inc. (NASDAQ:BDSX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Biodesix skyrockets 43%, expects FY revenue to beat guidance - MSN
BDSX Price Today: Biodesix, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Are Medical Stocks Lagging Aura Biosciences (AURA) This Year? - Yahoo Finance
BDSX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Biodesix (BDSX) Options Set for Delisting on April 20 - GuruFocus
Biodesix to Report First Quarter 2026 Financial Results on May 4, 2026 - 富途牛牛
Biodesix to highlight novel diagnostic test discovery and pipeline development at AACR 2026 - SelectScience
Biodesix plans May 4 Q1 results release, 4:30 p.m. ET webcast - Stock Titan
How Recent Shifts Are Reframing The Biodesix (BDSX) Investment Story - Yahoo Finance
Aberdeen Group plc Takes $1.78 Million Position in Biodesix, Inc. $BDSX - MarketBeat
Biodesix (NASDAQ: BDSX) outlines 2026 virtual meeting, board and pay votes - Stock Titan
Employees put Biodesix on USA TODAY's Top Workplaces list for a third year - Stock Titan
Rate Hike: Can Biodesix Inc expand into new marketsQuarterly Portfolio Report & Accurate Buy Signal Notifications - baoquankhu1.vn
Biodesix, Inc. (BDSX) stock price, news, quote and history - Yahoo Finance UK
Biodesix Unveils Novel Diagnostic Test at AACR 2026 - National Today
Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development - The Manila Times
Biodesix to Showcase Advances in Diagnostic Solutions at AACR Annual Meeting 2026 - Quiver Quantitative
Cancer test developer Biodesix brings 7 studies to AACR meeting - Stock Titan
Is Aura Biosciences (AURA) Stock Outpacing Its Medical Peers This Year? - qz.com
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):